Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
Parse Biosciences has raised $50.0M in total funding. The most recent round was Series C. The last funding was announced in December 2023.
Parse Biosciences's investors include National Science Foundation, Soleus Capital, Horizon Technology Finance, Janus Henderson Investors, Marshall Wace.
Parse Biosciences is headquartered in Seattle, United States.
Parse Biosciences is a biotechnology startup company that develops single-cell sequencing kit solutions for researchers.
Parse Biosciences is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Parse Biosciences — Funding & Investors." VCBacked, December 14, 2023, https://www.vcbacked.co/company/parse-biosciences. Accessed July 31, 2026.
VCBacked. (2023). Parse Biosciences — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/parse-biosciences
{{cite web |title=Parse Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/parse-biosciences |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated